Journal article
Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy
Blood, Vol.107(11), pp.4570-4571
06/2006
Abstract
Early therapy for hepatitis C virus (HCV) is associated with a high rate of viral clearance, but the long-term effects on immune responses remain controversial. The role of antibodies, both acutely and in the long term, is not clearly defined. We investigated these issues in a unique cohort of 7 individuals with primary antibody failure, who had received early interferon therapy after infection through contaminated immunoglobulin therapy a decade previously.
Details
- Title
- Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy
- Authors/Creators
- N. Semmo (Author/Creator)M. Lucas (Author/Creator)G. Krashias (Author/Creator)G. Lauer (Author/Creator)H. Chapel (Author/Creator)P. Klenerman (Author/Creator)
- Publication Details
- Blood, Vol.107(11), pp.4570-4571
- Publisher
- American Society of Hematology
- Identifiers
- 991005540479707891
- Copyright
- © American Society of Hematology
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
15 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.125 Hepatitis
- 1.125.83 HCV
- Web Of Science research areas
- Hematology
- ESI research areas
- Clinical Medicine